{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:11:22Z","timestamp":1790928682796,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key New Drug Creation and Manufacturing Program","award":["YFC1702605"],"award-info":[{"award-number":["YFC1702605"]}]},{"name":"National key inspection specialty construction projects","award":["YFC1702605"],"award-info":[{"award-number":["YFC1702605"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Vancomycin is regarded as the last resort of defense for a wide range of infections due to drug resistance and toxicity. The detection of vancomycin in plasma has always aroused particular concern because the performance of the assay affects the clinical treatment outcome. This article reviews various methods for vancomycin detection in human plasma and analyzes the advantages and disadvantages of each technique. Immunoassay has been the first choice for vancomycin concentration monitoring due to its simplicity and practicality, occasionally interfered with by other substances. Chromatographic methods have mainly been used for scientific research due to operational complexity and the particular requirement of the instrument. However, the advantages of a small amount of sample needed, high sensitivity, and specificity makes chromatography irreplaceable. Other methods are less commonly used in clinical applications because of the operational feasibility, clinical application, contamination, etc. Simplicity, good performance, economy, and environmental friendliness have been points of laboratory methodological concern. Unfortunately, no one method has met all of the elements so far.<\/jats:p>","DOI":"10.3390\/molecules27217319","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T09:01:42Z","timestamp":1667120502000},"page":"7319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["An Overview of Analytical Methodologies for Determination of Vancomycin in Human Plasma"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-3351","authenticated-orcid":false,"given":"Xin","family":"Cheng","sequence":"first","affiliation":[{"name":"Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Ma","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Su","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0025-7125(16)30041-4","article-title":"Vancomycin","volume":"79","author":"Cunha","year":"1995","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: Mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jpba.2008.05.040","article-title":"Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study","volume":"48","author":"Valle","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1080\/13880209.2016.1183684","article-title":"Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance","volume":"54","author":"Chu","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/AAC.03147-14","article-title":"Optimizing the Clinical Use of Vancomycin","volume":"60","author":"Molina","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_7","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: A review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jaocint\/qsz024","article-title":"Current Status of Vancomycin Analytical Methods","volume":"103","author":"Nascimento","year":"2020","journal-title":"J. AOAC Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/jcm.20.3.311-316.1984","article-title":"Laboratory evaluation of five assay methods for vancomycin: Bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay","volume":"20","author":"Pfaller","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/AAC.13.1.30","article-title":"Sensitive Bioassay for Vancomycin","volume":"13","author":"Walker","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/AAC.17.4.730","article-title":"Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides","volume":"17","author":"Walker","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/jcm.20.2.159-161.1984","article-title":"Comparison of fluorescence polarization immunoassay and bioassay of vancomycin","volume":"20","author":"Pohlod","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00007691-198406000-00019","article-title":"Comparison of Bioassay, High-Performance Liquid Chromatography, and Fluorescence Polarization Immunoassay for Quantitative Determination of Vancomycin in Serum","volume":"6","author":"Ristuccia","year":"1984","journal-title":"Ther. Drug Monit."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.17.4.654","article-title":"Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations","volume":"17","author":"Crossley","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/9.4.253","article-title":"Factors influencing the assay of antimicrobial drugs in clinical samples by the agar plate diffusion method","volume":"9","year":"1982","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/AAC.19.1.139","article-title":"Sensitive radioimmunoassay for vancomycin","volume":"19","author":"Fong","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/9.6.423","article-title":"The basis of immunoassays for antibiotics","volume":"9","author":"Munro","year":"1982","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jat\/5.5.236","article-title":"Fluorescence Polarization Immunoassay for the Determination of Therapeutic Drug Levels in Human Plasma","volume":"5","author":"Jolley","year":"1981","journal-title":"J. Anal. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00216-008-1897-z","article-title":"Fluorescence polarization immunoassays and related methods for simple, high-throughput screening of small molecules","volume":"391","author":"Smith","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00007691-198309000-00017","article-title":"Automated Fluorescence Polarization Immunoassay for Monitoring Vancomycin","volume":"5","author":"Schwenzer","year":"1983","journal-title":"Ther. Drug Monit."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0731-7085(98)00095-8","article-title":"A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX)","volume":"18","author":"Farin","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2017.04.003","article-title":"New liquid chromatography-tandem mass spec-trometry method for routine TDM of vancomycin in patients with both normal and impaired renal functions and comparison with results of polarization fluoroimmunoassay in light of varying creatinine concentrations","volume":"469","author":"Grundmann","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00007691-199011000-00009","article-title":"Measurement of Vancomycin in Renally Impaired Patient Samples Using a New High-Performance Liquid Chromatography Method with Vitamin B12 Internal Standard: Comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoassay methods","volume":"12","author":"Hu","year":"1990","journal-title":"Ther. Drug Monit."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2125.1999.00850.x","article-title":"The therapeutic monitoring of antimicrobial agents","volume":"47","author":"Begg","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_25","first-page":"2110","article-title":"Precision and accuracy of commercial assays for vancomycin therapeutic drug monitoring: Evaluation based on external quality assessment scheme","volume":"75","author":"Chen","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0731-7085(97)00140-4","article-title":"Quantitation of vancomycin and its crystalline degradation product (CDP-1) in human serum by high performance liquid chromatography","volume":"16","author":"Backes","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00007691-199602000-00013","article-title":"Instability of Standard Calibrators May Be Involved in Overestimating Vancomycin Concentrations Determined by Fluorescence Polarization Immunoassay","volume":"18","author":"Morishige","year":"1996","journal-title":"Ther. Drug Monit."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00007691-200108000-00020","article-title":"Fluorescence Polarization Immunoassay: Can It Result in an Overestimation of Vancomycin in Patients Not Suffering From Renal Failure?","volume":"23","author":"Sym","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00467-008-0877-z","article-title":"Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients","volume":"23","author":"Irtan","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/FTD.0b013e3181f01397","article-title":"Establishment of High-Performance Liquid Chromatography and Enzyme Multiplied Immunoassay Technology Methods for Determination of Free Mycophenolic Acid and Its Application in Chinese Liver Transplant Recipients","volume":"32","author":"Chen","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkg296","article-title":"Evaluation of commercial assays for vancomycin and aminoglycosides in serum: A comparison of accuracy and precision based on external quality assessment","volume":"52","author":"Wilson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/phar.2279","article-title":"Falsely Elevated Vancomycin Concentrations in a Patient Not Receiving Vancomycin","volume":"39","author":"Tsoi","year":"2019","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_33","first-page":"9","article-title":"Falsely elevated vancomycin-concentration values from enzyme immunoassay leading to treatment failure","volume":"77","author":"Singer","year":"2020","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1735-5362.301337","article-title":"A simple and validated HPLC method for vancomycin assay in plasma samples: The necessity of TDM center development in Southern Iran","volume":"15","author":"Ghasemiyeh","year":"2020","journal-title":"Res. Pharm. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0039-9140(01)00460-X","article-title":"Comparison of pyrolysis-mass spectrometry with high performance liquid chromatography for the analysis of vancomycin in serum","volume":"55","author":"Ghassempour","year":"2001","journal-title":"Talanta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/256963","article-title":"Simultaneous and Direct Determination of Vancomycin and Cephalexin in Human Plasma by Using HPLC-DAD Coupled with Second-Order Calibration Algorithms","volume":"2012","author":"Hu","year":"2012","journal-title":"J. Anal. Methods Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/chromsci\/bmx089","article-title":"A Rapid and Simple HPLC Method for Therapeutic Monitoring of Vancomycin","volume":"56","author":"Lima","year":"2017","journal-title":"J. Chromatogr. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchromb.2014.05.021","article-title":"Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: Impact of experimental conditions","volume":"961","author":"Kratzer","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00007691-199508000-00009","article-title":"An Improved Micromethod for Vancomycin Determination by High-Performance Liquid Chromatography","volume":"17","author":"Li","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40064-016-1778-4","article-title":"Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA)","volume":"5","author":"Usman","year":"2016","journal-title":"SpringerPlus"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/chromsci\/bms128","article-title":"Development of HPLC Methods for the Determination of Vancomycin in Human Plasma, Mouse Serum and Bronchoalveolar Lavage Fluid","volume":"51","author":"Hagihara","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2116\/analsci.26.755","article-title":"Rapid UHPLC Method for Simultaneous Determination of Vancomycin, Terbinafine, Spironolactone, Furosemide and Their Metabolites: Application to Human Plasma and Urine","volume":"26","author":"Baranowska","year":"2010","journal-title":"Anal. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchromb.2016.06.033","article-title":"Simultaneous determination and stability studies of linezolid, meropenem and vancomycin in bacterial growth medium by high-performance liquid chromatography","volume":"1028","author":"Wicha","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jchromb.2007.10.041","article-title":"Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography","volume":"860","author":"Bertoluci","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0041-87812001000500004","article-title":"Vancomycin monitoring in term newborns: Comparison of peak and trough serum concentrations determined by high performance liquid chromatography and fluorescence polarization immunoassay","volume":"56","author":"Feferbaum","year":"2001","journal-title":"Rev. Do Hosp. Das Cl\u00ednicas"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/FTD.0b013e3182a458bc","article-title":"Development and Validation of a New Ultra-Performance Liquid Chromatographic Method for Vancomycin Assay in Serum and Its Application to Therapeutic Drug Monitoring","volume":"36","author":"Cao","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0378-4347(00)00484-9","article-title":"New sensitive assay of vancomycin in human plasma using high-performance liquid chromatography and electrochemical detection","volume":"751","author":"Favetta","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00216-009-2948-9","article-title":"Determination of vancomycin in human plasma using high-performance liquid chromatography with fluorescence detection","volume":"395","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-4347(95)00033-F","article-title":"Rapid high-performance liquid chromatographic determination of vancomycin in human plasma","volume":"667","year":"1995","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(00)00307-7","article-title":"Rapid serum vancomycin assay by high-performance liquid chromatography using a semipermeable surface packing material column","volume":"301","author":"Furuta","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Liu, M., Yang, Z.-H., and Li, G.-H. (2018). A Novel Method for the Determination of Vancomycin in Serum by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Patients with Diabetic Foot Infections. Molecules, 23.","DOI":"10.3390\/molecules23112939"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4155\/bio-2018-0310","article-title":"An ultra-performance liquid chromatography\u2013tandem mass spectrometry method to quantify vancomycin in human serum by minimizing the degradation product and matrix interference","volume":"11","author":"Fan","year":"2019","journal-title":"Bioanalysis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4155\/bio-2018-0181","article-title":"Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography\/MS\/MS method for glycopeptide antibiotics determination in human plasma","volume":"10","author":"Forsdahl","year":"2018","journal-title":"Bioanalysis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1002\/jssc.202000691","article-title":"Simultaneous separation and determination of vancomycin and its crystalline degradation products in human serum by ultra high performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring","volume":"43","author":"Fan","year":"2020","journal-title":"J. Sep. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/1120009X.2016.1157947","article-title":"Ultra high performance liquid chromatography-tandem mass spectrometry vs. commercial immunoassay for determination of vancomycin plasma concentration in children. Possible implications for everyday clinical practice","volume":"28","author":"Barco","year":"2016","journal-title":"J. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/chromsci\/bmy060","article-title":"A LC\u2013MS-MS assay for simultaneous determination of two glycopeptides and two small molecule compounds in human plasma","volume":"56","author":"Shi","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4155\/bio-2017-0019","article-title":"An LC\u2013MS\/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent","volume":"9","author":"Parker","year":"2017","journal-title":"Bioanalysis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2014.12.012","article-title":"Novel LC\u2013MS\/MS method for plasma vancomycin: Comparison with immunoassays and clinical impact","volume":"441","author":"Oyaert","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jchromb.2007.07.041","article-title":"Determination of vancomycin in serum by liquid chromatography\u2013high resolution full scan mass spectrometry","volume":"857","author":"Zhang","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"122865","DOI":"10.1016\/j.jchromb.2021.122865","article-title":"Developing a SWATH capillary LC-MS\/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma","volume":"1179","author":"Xiao","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"ref_61","first-page":"1761","article-title":"Quantification of vancomycin in human serum by LC-MS\/MS","volume":"51","author":"Kobold","year":"2013","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.talanta.2013.07.043","article-title":"Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography\u2013tandem mass spectrometry","volume":"116","author":"Tsai","year":"2013","journal-title":"Talanta"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4155\/bio-2016-0157","article-title":"Simultaneous assay of multiple antibiotics in human plasma by LC\u2013MS\/MS: Importance of optimizing formic acid concentration","volume":"9","author":"Chen","year":"2017","journal-title":"Bioanalysis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchromb.2014.01.035","article-title":"A simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography\/tandem mass spectrometry and its applicability to a clinical study","volume":"951","author":"Bijleveld","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"113273","DOI":"10.1016\/j.jpba.2020.113273","article-title":"A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients","volume":"186","author":"Barco","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"122052","DOI":"10.1016\/j.talanta.2020.122052","article-title":"Recent advances in the determination of unbound concentration and plasma protein binding of drugs: Analytical methods","volume":"225","author":"Seyfinejad","year":"2020","journal-title":"Talanta"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2009.08.005","article-title":"Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections","volume":"34","author":"Berthoin","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jchromb.2014.08.002","article-title":"Determination of the free and total concentrations of vancomycin by two-dimensional liquid chromatography and its application in elderly patients","volume":"969","author":"Li","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jps.2600570216","article-title":"Colorimetric Assay and Improved Method for Identification of Vancomycin Hydrochloride","volume":"57","author":"Fooks","year":"1968","journal-title":"J. Pharm. Sci."},{"key":"ref_70","first-page":"763","article-title":"Voltametric Determination of Vancomycin in Dosage Forms through Treatment with Nitrous Acid","volume":"51","author":"Belal","year":"2001","journal-title":"Arzneimittelforschung"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0009-8981(01)00627-1","article-title":"Determination of vancomycin in human serum by micellar electrokinetic capillary chromatography with direct sample injection","volume":"312","author":"Kitahashi","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/elps.200600537","article-title":"Simultaneous determination of cefepime and vancomycin in plasma and cerebrospinal fluid by MEKC with direct sample injection and application for bacterial meningitis","volume":"28","author":"Yang","year":"2007","journal-title":"Electrophoresis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/molecules22040538","article-title":"Determination of Vancomycin in Human Serum by Cyclodextrin-Micellar Electrokinetic Capillary Chromatography (CD-MEKC) and Application for PDAP Patients","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.saa.2013.12.014","article-title":"CuO nanosheets-enhanced flow-injection chemiluminescence system for determination of vancomycin in water, pharmaceutical and human serum","volume":"122","author":"Khataee","year":"2013","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00604-019-4015-3","article-title":"A poly (acrylic acid)-modified copper-organic framework for electrochemical determination of vancomycin","volume":"187","author":"Gill","year":"2020","journal-title":"Mikrochim. Acta"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bios.2014.06.024","article-title":"Reversible detection of vancomycin using peptide-functionalized cantilever array sensor","volume":"62","author":"Bai","year":"2014","journal-title":"Biosens. Bioelectron."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"338250","DOI":"10.1016\/j.aca.2021.338250","article-title":"A fluorescence biosensor for therapeutic drug monitoring of vancomycin using in vivo microdialysis","volume":"1151","author":"Mu","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1021\/acssensors.9b01616","article-title":"Electrochemical Aptamer-Based Sensors for Improved Therapeutic Drug Monitoring and High-Precision, Feedback-Controlled Drug Delivery","volume":"4","author":"Yang","year":"2019","journal-title":"ACS Sensors"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1007\/s00216-019-02190-6","article-title":"A ratiometric fluorescent probe for sensitive determination of the important glycopeptide antibiotic vancomycin","volume":"411","author":"Deng","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1021\/ac402102j","article-title":"Direct Replacement of Antibodies with Molecularly Imprinted Polymer Nanoparticles in ELISA\u2014Development of a Novel Assay for Vancomycin","volume":"85","author":"Chianella","year":"2013","journal-title":"Anal. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-4939-6857-2_25","article-title":"Replacement of Antibodies in Pseudo-ELISAs: Molecularly Imprinted Nanoparticles for Vancomycin Detection","volume":"1575","author":"Canfarotta","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jfda.2017.06.005","article-title":"Stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of vancomycin hydrochloride in pharmaceuticals and spiked human plasma: Application to degradation kinetics","volume":"26","author":"Ibrahim","year":"2018","journal-title":"J. Food Drug Anal."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.17344\/acsi.2020.6107","article-title":"A New and Ecological Method to Quantify Vancomycin in Pharmaceutical Product by Infrared Spectrometry","volume":"68","author":"Nascimento","year":"2021","journal-title":"Acta Chim. Slov."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/21\/7319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:04:47Z","timestamp":1760144687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/21\/7319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":83,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["molecules27217319"],"URL":"https:\/\/doi.org\/10.3390\/molecules27217319","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}